Attached files
| file | filename |
|---|---|
| 10-K - 10-K - PLURISTEM THERAPEUTICS INC | zk1110396.htm |
| EX-31.1 - EXHIBIT 31.1 - PLURISTEM THERAPEUTICS INC | exhibit_31-1.htm |
| EX-14.1 - EXHIBIT 14.1 - PLURISTEM THERAPEUTICS INC | exhibit_14-1.htm |
| EX-10.8 - EXHIBIT 10.8 - PLURISTEM THERAPEUTICS INC | exhibit_10-8.htm |
| EX-10.5 - EXHIBIT 10.5 - PLURISTEM THERAPEUTICS INC | exhibit_10-5.htm |
| EX-32.1 - EXHIBIT 32.1 - PLURISTEM THERAPEUTICS INC | exhibit_32-1.htm |
| EX-32.2 - EXHIBIT 32.2 - PLURISTEM THERAPEUTICS INC | exhibit_32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - PLURISTEM THERAPEUTICS INC | exhibit_31-2.htm |
| EX-10.2 - EXHIBIT 10.2 - PLURISTEM THERAPEUTICS INC | exhibit_10-2.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement on Form S-3 (Registration No. 333-171334, 333-170859 and 333-151761) and in the Registration Statements on Form S-8 (Registration No. 333-173777, 333-162577 and 333-111591) of Pluristem Therapeutics Inc. of our report dated September 7, 2011, with respect to the consolidated financial statements of Pluristem Therapeutics, Inc. included in this Annual Report (Form 10-K) for the year ended June 30, 2011.
| /s/ Kost Forer Gabbay & Kasierer
Kost Forer Gabbay & Kasierer
A member of Ernst & Young Global
|
Haifa, Israel
September 7, 2011